Contact us at +1.844.4AVIENT (1.844.428.4368).

Contact your Mesa representative for details.

By increasing droplet contact angles, fluids are more easily repelled or evacuated from a container.

Media Contact Nicole DeChant Avient Corporation nicole.dechant@avient.com Media Relations Contacts Company Officers

Media Contact Nicole DeChant Avient Corporation nicole.dechant@avient.com Media Relations Contacts Company Officers

A Great Place to Work With all the time, effort and resources we invest to build our culture and support our associates, we have been honored to receive awards that showcase our company and people.

12950 Worldgate Drive, Suite 800, Herndon, VA 20170-6007 USA A Member of the BSI Group of Companies. Americas Headquarters: BSI Group America Inc., 12950 Worldgate Drive, Suite 800, Herndon, VA 20170-6007 USA A Member of the BSI Group of Companies.

Comprehensive consulting and testing expertise for medical materials and device companies Committed to Growing with the Medical Industry Since 2009, PDI has invested over $2 million to improve and extend our capabilities to serve our medical materials and device clients. Benefi ts: As a result of side-by-side R&D and laboratory work, the two companies ultimately optimized a proprietary method for bonding the polymer disc and titanium plates. Benefi ts: As a result of side-by-side R&D and laboratory work, the two companies ultimately optimized a proprietary method for bonding the polymer disc and titanium plates.

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation  PolyOne’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of the Company and each business segment and to allocate resources. Appendix Q3 2014 Financial Highlights At a Glance�Global Color, Additives and Inks At a Glance�Global Specialty Engineered Materials At a Glance�Designed Structures and Solutions At a Glance�Performance Products and Solutions At a Glance�Distribution Plastics: Key to Future Sustainable Development Commitment to Operational Excellence Application Examples Slide Number 28 Anti-Counterfeiting Solutions 2012 Range Rover Evoque Interior Slide Number 31 Metal Replacement Solutions Next Generation Solar Charger High-Barrier Packaging Containers Aerospace Applications Non GAAP Rec - 11 5 14.pdf Sidoti & Company non-GAAP Rec

ACTIVE INGREDIENTS RESISTANCE RATING Clorox® Disinfecting Wipes 5813-79 Quaternary ammonium +++++ +++++ +++++ ++ +++ ++++ Formula 409® Heavy Duty Degreaser N/A Lauramine oxide, ethanolamine +++++ +++++ +++++ + ++ +++ Lysol® All-Purpose Cleaner 777-66 Quaternary ammonium +++++ +++++ +++++ + + ++ $$$ $$$ $$$$ $ $$$ $ MATERIAL COMPARISON WITH COMMON CONSUMER DISINFECTANTS FR P C/ AB S FR P C/ P ET FR P C/ P BT Ed ge te k™ E T8 90 0 CR Ed ge te k™ E T8 90 0 H I C R Ed ge te k™ E T8 92 0 FR C RCRITERIA FOR RESISTANCE RATING + strength and elongation at yield retention between 90-110% + strength and elongation at yield retention between 75-125% + no statistically significant reduction in elongation at break (p < 0.05) + visual observation score of 4 or better (minor/no crazing, no cracks) + samples survived disinfectant exposure in strain jig Lysol® is a trademark of Reckitt Benckiser LLC Formula 409® is a trademark of The Clorox Company Clorox® is a trademark of The Clorox Company An independent, A2LA-accredited lab tested the following polymers with various disinfectants to help customers choose the material suitable for their specific application requirements.